Abstract
Monitoring tuberculosis (TB) treatment success is crucial for clinical decision-making. The only available tool in this regard is sputum microscopy, but it has demerits. Moreover, in case of smear negatives and extrapulmonary TB, an efficient tool is still sought for. Therefore, we evaluated T regulatory cell (Treg)-associated markers (CD25, CD39, and FoxP3) and cellular subsets in monitoring treatment success in treatment-completed groups. Expression profile of various markers and subsets were compared real time among treatment-naive pulmonary TB patients (TN-PTB), followed-up treatment-completed (TC-fu) cohort, and a not followed-up (TC-nfu) cohort. Peripheral blood mononuclear cells from various groups were incubated overnight and were stained with antibodies for specific markers and studied by flow cytometry. In both the treatment-completed groups, a decline in frequencies of CD25+ marker and CD4+CD25+, CD4+CD25+FoxP3, CD4+CD25+CD39+ Treg was observed with clearance of infection, indicating their potential in monitoring treatment success. However, in the case of treatment failure patient (Tfp), a drastic increase in frequency of CD4+CD25+FoxP3+ Treg subset was found, indicating its usefulness in predicting treatment failure...Continue Reading
References
Dec 13, 2005·American Journal of Respiratory and Critical Care Medicine·Valerie Guyot-RevolAjit Lalvani
Mar 18, 2006·Clinical and Experimental Immunology·R Ribeiro-RodriguesC S Hirsch
Jan 20, 2007·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Xinchun ChenEmmanuel Katsanis
Jun 1, 2010·The Lancet Infectious Diseases·David J HorneKaren R Steingart
Jul 27, 2010·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Ying E WuKe Li
Jan 5, 2011·Clinical & Developmental Immunology·Kerry J WelshRobert L Hunter
Nov 1, 2011·Clinical and Vaccine Immunology : CVI·Alexandre S de AlmeidaSpyros A Kalams
Jun 6, 2012·Tuberculosis Research and Treatment·E G ChurinaV V Novitskiy
Oct 3, 2012·PloS One·Amar SinghDipendra Kumar Mitra
Jul 3, 2013·Tuberculosis·Hyo-Jeong LimJae Ho Lee
Jul 5, 2013·PloS One·Dolly Jackson-SillahHazel M Dockrell
Oct 15, 2014·Clinical and Experimental Immunology·Siri L FeruglioAnne Ma Dyrhol-Riise
May 8, 2015·Immunologic Research·Om ParkashM Madhan Kumar
Sep 2, 2015·The Journal of Clinical Investigation·Toidi AdekambiJyothi Rengarajan
Oct 16, 2015·The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·N LiH Wang
Feb 24, 2018·Frontiers in Immunology·Sonali AgrawalM Madhan Kumar
May 25, 2016·Journal of Clinical Tuberculosis and Other Mycobacterial Diseases·Adam J Caulfield, Nancy L Wengenack